Arthritis News > Corticosteroids Linked to Cardiovascular Events Corticosteroids Linked to Cardiovascular Events in Rheumatoid Arthritis Corticosteroids are associated with an increased risk of cardiovascular (CV) disease in the general population.  However, there are conflicting data on the CV risk of corticosteroids in RA, as their potent anti-inflammatory properties may result in a net beneficial [...]

Arthritis News > Demand Growing for Rheumatologists Demand for Rheumatologists Expected to Exceed Supply in Coming Decades An increase in older adults combined with a greater ability to effectively manage many inflammatory musculoskeletal disorders is expected to require an increase in the number of practicing rheumatologists over the coming decades.  In order to anticipate and [...]

Arthritis News > Coffee Consumption and the Development of Gout Coffee Consumption May Protect Against the Development of Gout Dietary risk factors, such as meat and alcohol consumption, are well recognized as contributing factors to gout flares in patients with established gout.  These same factors have been shown to associate with elevated serum uric acid [...]

Home > Arthritis News > 2006 The IL-6 Receptor Antagonist Tocilizumab Shows Promise for the Treatment of RA Il-6 is a highly inflammatory cytokine that is produced in abundance in RA. It has many pathogenic effects involved in the amplification of the inflammatory response and in direct destruction of bone and cartilage. Tocilizumab, a humanized [...]

Home > Arthritis News > 2006 Effectiveness of Combination Therapy vs. Monotherapy with Etanercept or Infliximab in Real-World Clinical Practice Efficacy studies of TNF inhibitors in rheumatoid arthritis (RA), such as TEMPO, have shown that initial therapy with a TNF inhibitor + methotrexate combination is superior to either drug used as monotherapy. However, in clinical [...]